Aims to enable more efficient global delivery of discovery projects
Charnwood Molecular and Aurelia Bioscience, both with labs at BioCity Nottingham, have expanded their alliance aimed at enabling more efficient global delivery of discovery projects to pharma/biopharma clients.
Aurelia Bioscience specializes in the development of bioassays and the screening of compounds for initial hit identification at medium/high throughput and on-going compound refinement in the hit/lead stages of medicinal chemistry programs.
Compounds for the various stages of these programs are provided by Charnwood Molecular, which provides synthetic chemistry services across a range of therapeutic areas.
According to the companies, working at the same site enables the partners to accelerate discovery program efforts through agile design cycles along with high value scientific input.
